Last reviewed · How we verify
Combining free gingival graft with frenotomy procedure
Combining free gingival graft with frenotomy procedure is a Biologic drug developed by Cairo University. It is currently FDA-approved.
At a glance
| Generic name | Combining free gingival graft with frenotomy procedure |
|---|---|
| Sponsor | Cairo University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Combining free gingival graft with frenotomy procedure CI brief — competitive landscape report
- Combining free gingival graft with frenotomy procedure updates RSS · CI watch RSS
- Cairo University portfolio CI
Frequently asked questions about Combining free gingival graft with frenotomy procedure
What is Combining free gingival graft with frenotomy procedure?
Combining free gingival graft with frenotomy procedure is a Biologic drug developed by Cairo University.
Who makes Combining free gingival graft with frenotomy procedure?
Combining free gingival graft with frenotomy procedure is developed and marketed by Cairo University (see full Cairo University pipeline at /company/cairo-university).
What development phase is Combining free gingival graft with frenotomy procedure in?
Combining free gingival graft with frenotomy procedure is FDA-approved (marketed).